PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 9, Pages 1411-1417
Publisher
Wiley
Online
2013-03-23
DOI
10.1002/pbc.24532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Inconvenience of Convenience Cohorts: Rhabdomyosarcoma and the PAX-FOXO1 Biomarker
- (2012) A. R. Rosenberg et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic and Clinical Analysis of Amplification of the 13q31 Chromosomal Region in Alveolar Rhabdomyosarcoma: A Report from the Children's Oncology Group
- (2011) Jennifer L. Reichek et al. CLINICAL CANCER RESEARCH
- PAX3/7–FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization
- (2011) Sarah N. Dumont et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the cooperative soft tissue sarcoma study group (CWS)
- (2011) Sabine Stegmaier et al. PEDIATRIC BLOOD & CANCER
- Fusion-Negative Alveolar Rhabdomyosarcoma: Modification of Risk Stratification Is Premature
- (2010) James R. Anderson et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group
- (2010) Elai Davicioni et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosing Alveolar Rhabdomyosarcoma: Morphology Must Be Coupled With Fusion Confirmation
- (2010) Leonard H. Wexler et al. JOURNAL OF CLINICAL ONCOLOGY
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of Diagnosis
- (2009) Elai Davicioni et al. AMERICAN JOURNAL OF PATHOLOGY
- Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group
- (2009) Frederic G. Barr et al. GENES CHROMOSOMES & CANCER
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Metastatic Rhabdomyosarcomas: Results of a Pooled Analysis From United States and European Cooperative Groups
- (2008) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct multiplexed measurement of gene expression with color-coded probe pairs
- (2008) Gary K Geiss et al. NATURE BIOTECHNOLOGY
- Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas
- (2008) S. L. Spunt et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now